Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial

Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record provides details of Novartis’s completed Phase 1 fevipiprant study, including its purpose, eligibility criteria, locations, study design, and outcome measures. It also includes study dates and links to related trial information.
    Difference
    43%
    Check dated 2026-11-08T05:16:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T02:18:42.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence,” with updates and FAQs available.
    Difference
    1%
    Check dated 2026-10-25T02:16:30.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:08:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:05:49.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the full trial details for NCT03048448. This blocks access to the study information and related sections on ClinicalTrials.gov.
    Difference
    17%
    Check dated 2026-09-20T01:22:57.000Z thumbnail image

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.